Yahoo
NasdaqGS - Delayed Quote USD

BioNTech SE (BNTX)

103.76 +0.88 (+0.86%)
At close: September 4 at 4:00:01 PM EDT
103.76 0.00 (0.00%)
After hours: September 4 at 7:30:04 PM EDT
Trade BNTX on Coinbase

News headlines

Updated 9m ago
Powered by Yahoo Scout

BioNTech (BNTX) faces a setback after discontinuing its Phase II colorectal cancer trial, resulting in an 8% stock drop. The company also received FDA approval for its COVID-19 vaccine, which may provide some market stability amid pipeline concerns.

Mobilize your Website
View Site in Mobile | Classic
Share by: